BLFE — Biolife Sciences Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.29m
2010 November 30th | 2011 November 30th | 2012 November 30th | 2020 November 30th | 2021 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | 10-K | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.72 | -0.293 | -0.202 | -1.27 | -0.457 |
Amortisation | |||||
Non-Cash Items | 0.041 | 0.227 | 0.153 | 0.004 | 0.162 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0 | 0.013 | 0.013 | 0.263 | 0.188 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 1.76 | -0.04 | -0.037 | -1 | -0.107 |
Capital Expenditures | — | — | — | -0.001 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.545 | 0 | 0 | — | — |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.545 | 0 | 0 | -0.001 | 0 |
Financing Cash Flow Items | -1.53 | 0.037 | 0.034 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.22 | 0.038 | 0.034 | 0.989 | 0.075 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.004 | -0.002 | -0.003 | 0.035 | -0.018 |